|
| Status |
Public on Aug 01, 2013 |
| Title |
T24 Clorgyline |
| Sample type |
genomic |
| |
|
| Source name |
bladder
|
| Organism |
Homo sapiens |
| Characteristics |
gender: Female
cell line: T24
treatment: Clorgyline
|
| Extracted molecule |
genomic DNA |
| Extraction protocol |
genomic DNA was extracted and purified by phenol chloroform extractions
|
| Label |
Cy5 and Cy3
|
| Label protocol |
Standard Illumina Protocol
|
| |
|
| Hybridization protocol |
bisulphite converted DNA was amplified, fragmented and hybridised to Illumina Infinium Human Methylation HM450 Beadchip using standard Illumina protocol
|
| Scan protocol |
Arrays were imaged using BeadArray Reader using standard recommended Illumina scanner setting
|
| Description |
Human bladder carcinoma cell line
|
| Data processing |
BeadStudio software v3.2
|
| |
|
| Submission date |
Oct 11, 2012 |
| Last update date |
Aug 01, 2013 |
| Contact name |
Xiaojing Yang |
| E-mail(s) |
xiaojiny@usc.edu
|
| Phone |
(323)865-0740
|
| Organization name |
USC/Norris Comprehensive Cancer Center
|
| Street address |
1441 Eastlake Ave, Room 7336
|
| City |
Los Angeles |
| State/province |
CA |
| ZIP/Postal code |
90033 |
| Country |
USA |
| |
|
| Platform ID |
GPL13534 |
| Series (2) |
| GSE41525 |
Combinatorial treatment of DNMT inhibitor and LSD1 inhibitor results in cell growth inhibition and reexpression of epigenetically silenced genes (methylation) |
| GSE41754 |
Combinatorial treatment of DNMT inhibitor and LSD1 inhibitor results in cell growth inhibition and reexpression of epigenetically silenced genes |
|
